FoodAug 21, 2019
Kerry Batter Mix, Item Number 30753153.49, Net Wt recall — FDA F-2001-2019
Product contains foreign material (nylon string)
Class IIFDA: TerminatedKerry, Inc.
Monthly breakdown
2019 recalls by month
Select a month to review the recall records reported during that period.
December 2019321 records · 4 categoriesNovember 2019597 records · 4 categoriesOctober 2019525 records · 4 categoriesSeptember 2019268 records · 4 categoriesAugust 2019505 records · 4 categoriesJuly 2019680 records · 4 categoriesJune 2019445 records · 4 categoriesMay 2019396 records · 4 categoriesApril 2019242 records · 4 categoriesMarch 2019250 records · 4 categoriesFebruary 2019381 records · 4 categoriesJanuary 2019142 records · 4 categories
2019 recalls — page 81
Records are ordered by the best available source date.
FoodAug 21, 2019
Kerry Batter Mix, Item Number 30753358.49, Net Wt recall — FDA F-2048-2019
Product contains foreign material (nylon string)
Class IIFDA: TerminatedKerry, Inc.
FoodAug 21, 2019
Kerry Breader CFS, Item Number 30753188.49, Net Wt recall — FDA F-2013-2019
Product contains foreign material (nylon string)
Class IIFDA: TerminatedKerry, Inc.
FoodAug 21, 2019
Kerry Sweet Onion Crusted Batter, Item Number 30753307.49, Net Wt recall — FDA F-2040-2019
Product contains foreign material (nylon string)
Class IIFDA: TerminatedKerry, Inc.
FoodAug 21, 2019
Kerry Scallopini Breader, Item Number 30753197.49, Net Wt recall — FDA F-2020-2019
Product contains foreign material (nylon string)
Class IIFDA: TerminatedKerry, Inc.
FoodAug 21, 2019
Kerry Predust/Batter, Item Number 30753195.49, Net Wt recall — FDA F-2019-2019
Product contains foreign material (nylon string)
Class IIFDA: TerminatedKerry, Inc.
FoodAug 21, 2019
Kerry Breader, Item Number 30753150.49, Net Wt recall — FDA F-1998-2019
Product contains foreign material (nylon string)
Class IIFDA: TerminatedKerry, Inc.
DrugAug 21, 2019
US Pharmaceuticals Children Glycerin Suppositories Laxative for ages 2 to 5 recall — FDA D-1727-2019
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Class IIFDA: TerminatedUS Pharmaceuticals Inc.
DrugAug 21, 2019
Infusion Options OXALIPLATIN 145 MG /250 ML D5W IVPB recall — FDA D-1797-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
DrugAug 21, 2019
US Pharmaceuticals CVS Health Glycerin Suppositories, 50-count box recall — FDA D-1724-2019
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Class IIFDA: TerminatedUS Pharmaceuticals Inc.
DrugAug 21, 2019
Infusion Options ERIBULIN 1.12 MG / 100 ML NS IVPB recall — FDA D-1775-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
DrugAug 21, 2019
Infusion Options Fluorouracil 560 MG / 11.2 ML IVP recall — FDA D-1777-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
DrugAug 21, 2019
WALGREENS ADULT GLYCERIN Adult Glycerin Suppositories, Package Size 25-count suppositories recall — FDA D-1728-2019
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Class IIFDA: TerminatedUS Pharmaceuticals Inc.
DrugAug 21, 2019
US Pharmaceuticals CVS Therapeutic Menthol Gel, 8 FL OZ (227 g) recall — FDA D-1726-2019
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Class IIFDA: TerminatedUS Pharmaceuticals Inc.
DrugAug 21, 2019
Infusion Options CARBOPLATIN 174 MG / 250ml NS IVPB recall — FDA D-1756-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
DrugAug 21, 2019
MAXIMUM STRENGTH HYDROCORTISONE CREAM Hydrocortisone Cream, Hydrocortisone 1% / Anti-Itch recall — FDA D-1734-2019
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Class IIFDA: TerminatedUS Pharmaceuticals Inc.
DrugAug 21, 2019
American Health Packaging Aspirin and Extended-release Dipyridamole Capsules, 25 mg/200 mg recall — FDA D-1820-2019
Failed Impurities/Degradation Specifications; out of specification result for an unknown impurity in stability samples.
Class IIFDA: TerminatedAmerican Health Packaging
DrugAug 21, 2019
Infusion Options RITUXIMAB 575 MG / 250 ml 0.9% NACL IVPB recall — FDA D-1810-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
DrugAug 21, 2019
Infusion Options NIVOLUMAB 480 MG / 100 ML NS IVPB recall — FDA D-1793-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
DrugAug 21, 2019
Lisinopril and Hydrochlorothiazide Tablets USP, 10 mg/12.5 mg, 100 tablet bottle recall — FDA D-1720-2019
Presence of Foreign Substance; Product complaints received related to brownish/blackish stains on the tablets and brownish/blackish powder observed inside the bottles.
Class IIFDA: TerminatedLupin Pharmaceuticals Inc.
DrugAug 21, 2019
US Pharmaceuticals Soothe&Cool Protect Moisture Guard Skin Protectant, 3.5 oz. (99 g), tube recall — FDA D-1735-2019
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Class IIFDA: TerminatedUS Pharmaceuticals Inc.
DrugAug 21, 2019
MAXIMUM STRENGTH HYDROCORTISONE CREAM WITH ALOE Hydrocortisone Cream With Aloe recall — FDA D-1732-2019
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Class IIFDA: TerminatedUS Pharmaceuticals Inc.
DrugAug 21, 2019
Infusion Options Doxorubicin Liposomal 71 MG / 250 ML D5W IVPB recall — FDA D-1771-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
DrugAug 21, 2019
Infusion Options RITUXAN 728 MG QS 728 mL 0.9% NACL IVPB recall — FDA D-1809-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedInfusion Options, Inc.
About the 2019 recall archive
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.